This new form of treatment for metastatic prostate cancer is being used in Europe, Australia and elsewhere, and being tested in clinical trials in the U.S. As part of my series on PSMA-targeting, here’s more of the story: Neil Bander, M.D., Director of Urological Oncology Research at Weill Cornell and a pioneer in the study […]
There’s some bright hope on the horizon for men with metastatic prostate cancer: it’s PSMA-targeting therapy. This is different from PSMA-targeted imaging, which shows where small bits of prostate cancer are hiding in the body. But it uses the very same building blocks. Think of molecular LEGOS: Instead of attaching the tracer molecule that can “see” […]
Who’s a survivor? You are, if you are trying to get your life back after a diagnosis of prostate cancer. Survivor. What does that word bring to mind? (Besides, of course, the name of the rock band whose song, “Eye of the Tiger,” went double-platinum in 1982 and was the theme of “Rocky […]
Just hear me out here. Look: I get it. I come from a high-risk prostate cancer family, with five beloved men, including my husband, my dad, his dad, his grandfather, and my grandfather affected so far. So you know I am not ever going to downplay the risk. But enough! Let’s stop being afraid of […]
Imagine looking at a very young Ian McKellen, the knighted British actor, and thinking, “Half a century from now, if they ever film the Lord of the Rings trilogy, he could be the best Gandalf ever!” That kind of vision is rare – but scientist Neil Bander, M.D., has it. Nearly three decades ago, Bander, […]
Maybe you’ve been diagnosed with high-risk prostate cancer. Maybe you have already been treated for prostate cancer, but your PSA is starting to creep back up, which means that the treatment didn’t get all of the cancer – but maybe it’s just right there in the prostate area, easily targetable with radiation. Or maybe it’s […]
A full-on assault of high-risk prostate cancer with intensive neoadjuvant hormonal therapy before surgery marks a huge shift in medical thinking. Instead of doing things in a well-ordered sequence, oncologists like UCSD’s Rana McKay are launching many weapons earlier than ever, when cancer is less prepared for battle, and they’re going for a cure. Why […]